New $17 million grant establishes LJI as global hub for immunology data curation and analysis

A new grant of over $17 million from the National Institute of Allergy and Infectious Diseases (NIAID) has established La Jolla Institute for Immunology (LJI) as the leading institute for human immunology data curation, analysis, and dissemination. With this funding, LJI has taken the helm of the Human Immunology Project Consortium Data Coordinating Center, a critical tool in the effort to fuel scientific collaboration in immunoprofiling and highlight findings from the overall Human Immunology Project Consortium (HIPC).

Researchers Identify Potential Target for Treating Autoimmune Diseases

New research using a mouse model for multiple sclerosis has uncovered a potential new area to explore for possible treatments for autoimmune disorders.

Study Finds Systemic Autoimmune Disease Patients Fare Well After Transplants, Making Surgery a Viable Treatment Option for End-Stage Lung Disease

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with systemic autoimmune diseases do as well after lung or heart-lung transplants as those without any systemic causes of end-stage lung disease.

Expert Alert: Encephalitis prevention another reason to receive COVID-19 vaccine

Patients with COVID-19 are at risk for neurologic complications, including encephalitis, or inflammation of the brain.

“Encephalitis cases have been reported in patients with COVID-19, although on the whole it appears to be a relatively rare complication,” says Michel Toledano, M.D., a Mayo Clinic neurologist.

In the case of encephalitis caused by communicable diseases for which there is a vaccine available, getting vaccinated is the best way of preventing the disease.

Physicians issue warning about rare neurological condition, expected to appear this fall

Pediatricians Henry David, MD, and Madan Kumar, DO, of the University of Chicago Medicine Comer Children’s Hospital warn parents of young children to watch out for symptoms of acute flaccid myelitis (AFM), a rare neurological disorder linked to viral infections that can lead to permanent paralysis.

American College of Rheumatology Secures $7M Grant to Address Gaps in Lupus Care and Treatment

The American College of Rheumatology (ACR) was recently awarded a $7M grant to reduce inequities in symptom recognition, care and disease management of systemic lupus erythematosus (lupus). The grant, which will be led by the ACR’s Collaborative Initiatives (COIN) department, begins on Sept. 30.

Pregnant mother’s immunity tied to behavioral, emotional challenges for kids with autism

Children with autism born to mothers who had immune conditions during their pregnancy are more likely to have behavioral and emotional problems, a UC Davis Health study has found. Offspring sex may also interact with maternal immune conditions to influence outcomes, particularly in terms of a child’s cognition.

DNA Misfolding in White Blood Cells Increases Risk for Type 1 Diabetes

Researchers found, in mice, that changes in DNA sequence can trigger the chromosomes to misfold in a way that puts one at a heightened risk for Type 1 diabetes. The study revealed that differences in DNA sequences dramatically changed how the DNA was folded inside the nucleus, ultimately affecting the regulation of genes linked to the development Type 1 diabetes.

AARDA Partners with AutoimmuneMom

Detroit, MI (January 30, 2019) – The American Autoimmune Related Disease Association (AARDA) is thrilled to announce our new partnership with AutoimmuneMom. For the last seven+ years, AutoimmuneMom has created a digital community through the hard work and dedication of Katie Cleary. Now, AARDA will proudly host the content that has brought together people with autoimmune disease through stories of how autoimmune disease impacts motherhood and pregnancy, general autoimmune information, personal stories, and doctor recommendations. AutoimmuneMom will continue to maintain its social media presence, but all website content will be hosted on AARDA.org.

Cedars-Sinai Receives $20M to Create Kao Autoimmunity Institute

Cedars-Sinai today announced a $20 million gift from Dr. and Mrs. Min H. Kao and the Kao Family Foundation to create the Kao Autoimmunity Institute to advance research and treatment of rheumatologic diseases. The gift also will establish the Scleroderma Program within the institute to provide interdisciplinary and integrated care for scleroderma patients and to support research, outreach, training and education to help those with the disease.

Study: First Evidence of Immune Response Targeting Brain Cells in Autism

In a paper published in Annals of Neurology, a physician-scientist at Beth Israel Deaconess Medical Center (BIDMC), and colleagues report the presence of cellular features consistent with an immune response targeting specialized brain cells in more than two thirds of autistic brains analyzed postmortem. These cellular characteristics – not previously observed in autism – lend critical new insight into autism’s origins and could pave the way to improved diagnosis and treatment for people with this disorder.